FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

PRAXIS

44.95
-0.2 (-0.44%)
Updated 03:28 28/07 IST

PRAXIS Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for PRAXIS
Disclaimer
0% Bullish
0% Bearish

PRAXIS Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See PRAXIS Share Price Targets >>

PRAXIS Ratings

Long term PRAXIS rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live PRAXIS message board: Is PRAXIS buy or sell? Should I buy PRAXIS shares? Why are PRAXIS shares falling? Should I invest in PRAXIS stock?

  1. Home
  2. PRAXIS Forum

PRAXIS Share Price Discussion


Double Your wealth with DAILY PROFITS
MULTIBAGGER TIME 8 MONTHS
DATE 7-Jul
BUY PRAXIS HOME: 52-46
STOPLOSS :40
TARGET :186

Like
Reply
N
Reputation: 14,979 • Apr 16 12:01 PM
Praxis Global Alliance appoints Sumit Goel as a managing partner
Based in Mumbai, Goel will be responsible for cost and operational excellence, revenue and growth, customer experience, business transformation, commercial diligence, post-merger integration, deal-value unlocking for Praxis clients globally.
The Economic Times
Like
Reply
Like
Reply
N
Reputation: 14,979 • Jun 30, 2020 3:43 AM
Praxis Home Ret Standalone March 2020 Net Sales at Rs 152.68 crore, down 4.05% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 14,979 • Sep 26, 2019 1:58 AM
Stocks in the news: DHFL, Cipla, GSK Pharma, Sterlite Tech, Future Enterprises, CG Power, SRF
DHFL | Cipla | GlaxoSmithKline Pharma | Adani Enterprises | Future Enterprises and Sterlite Technologies are among stocks which are in news today.
Moneycontrol
Like
Reply
N
Reputation: 14,979 • Sep 26, 2019 1:43 AM
Stocks in the news: DHFL, Cipla, GSK Pharma, Adani Enterprises, Future Enterprises, CG Power, SRF
DHFL | Cipla | GlaxoSmithKline Pharma | Adani Enterprises | Future Enterprises and Sterlite Technologies are among stocks which are in news today.
Moneycontrol
Like
Reply
N
Reputation: 14,979 • Aug 7, 2019 11:38 AM
Praxis Home Ret Standalone June 2019 Net Sales at Rs 162.19 crore, up 2.2% Y-o-Y
moneycontrol.com
Like
Reply
N
Reputation: 14,979 • May 24, 2019 4:03 AM
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • PRAXIS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization455.22
    Enterprise Value463.45
    Price to EarningsNA
    Price to Book Value10.59
    Return on Capital EmployedNA
    Return on Equity-0.03
    Face Value5
    Dividend YieldNA
  • PRAXIS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 2846.847.24343.95
    Jul 2746.0548.544.7545.15
    Jul 26494945.946.85
    Jul 2348.848.846.647.95
    Jul 224747.8546.546.85
  • PRAXIS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹47.85
    30 Day Moving Average₹46.49
    50 Day Moving Average₹44.68
    100 Day Moving Average₹44.3
    200 Day Moving Average₹39.13
  • PRAXIS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue380.546.6556.22
    Operating Profit-2.59-20.19-0.87
    Profit Before Tax-2.77-20.21-0.86
    Net Income-1.99-20.06-0.9
  • PRAXIS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds4370.18-0.39
    Total Liabilities340277.750.22
    Total Assets384347.930.1
  • PRAXIS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity0.76-1.57-1.48
    Cash from Investing Activity3.912.320.69
    Cash from Financing Activity-0.870.04-22.75
    Net Cash Flow3.80.793.81
  • PRAXIS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.01-3.57
    Return on Equity-0.031
    Return on Capital EmployedNANA
  • PRAXIS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in RevenueNA
    3 Year CAGR Growth in Operating Profit1
    3 Year CAGR Growth in EBIDTANA
    3 Year CAGR Growth in Net Income1
    3 Yr CAGR Growth - Diluted EPS1
  • PRAXIS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in RevenueNA
    5 Year CAGR Growth in Operating Profit-1,008.5
    5 Year CAGR Growth in EBIDTANA
    5 Year CAGR Growth in Net Income-1,002
    3 Yr CAGR Growth - Diluted EPS-199.6
  • PRAXIS - Recent News

    keyboard_arrow_down
    NewsBot
    Apr 16 12:01 PM
    Praxis Global Alliance appoints Sumit Goel as a managing partner
    The Economic Times
    NewsBot
    Feb 2 5:18 AM
    NewsBot
    Oct 29, 2020 3:48 AM
    NewsBot
    Jun 30, 2020 3:43 AM
    Praxis Home Ret Standalone March 2020 Net Sales at Rs 152.68 crore, down 4.05% Y-o-Y
    Moneycontrol
    NewsBot
    Sep 26, 2019 1:58 AM
    Stocks in the news: DHFL, Cipla, GSK Pharma, Sterlite Tech, Future Enterprises, CG Power, SRF
    Moneycontrol
    NewsBot
    Sep 26, 2019 1:43 AM
    Stocks in the news: DHFL, Cipla, GSK Pharma, Adani Enterprises, Future Enterprises, CG Power, SRF
    Moneycontrol
    NewsBot
    Aug 7, 2019 11:38 AM
    Praxis Home Ret Standalone June 2019 Net Sales at Rs 162.19 crore, up 2.2% Y-o-Y
    moneycontrol.com
    NewsBot
    May 24, 2019 4:03 AM
    NewsBot
    Feb 5, 2019 11:37 AM
    NewsBot
    Nov 5, 2018 9:37 AM
  • PRAXIS - Related Communities

    keyboard_arrow_down
    Avenue Supermarts Ltd. NSE: DMART | B...
    Future Retail Ltd. NSE: FRETAIL | BSE...
    Trent Ltd. NSE: TRENT | BSE: 500251 |...
    V-Mart Retail Ltd. NSE: VMART | BSE: ...
    Aditya Birla Fashion and Retail Ltd. ...
    Spencer's Retail Ltd. NSE: SPENCERS |...
    Future Enterprises Ltd. NSE: FEL | BS...
    Shoppers Stop Ltd. NSE: SHOPERSTOP | ...
    Future Lifestyle Fashions Ltd. NSE: F...
    V2 Retail Ltd. NSE: V2RETAIL | BSE: 5...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020